The Prevalence, Magnitude, and Reversibility of Elevated Liver Enzyme Activities in Hyperthyroid Cats Presenting for Iodine-131 Treatment
- PMID: 35252423
- PMCID: PMC8890775
- DOI: 10.3389/fvets.2022.830287
The Prevalence, Magnitude, and Reversibility of Elevated Liver Enzyme Activities in Hyperthyroid Cats Presenting for Iodine-131 Treatment
Abstract
Objectives: The primary objective of this study was to report the prevalence and magnitude of elevated liver enzyme activity in feline hyperthyroidism using a large cohort of cats presenting for iodine-131 treatment. The secondary objective was to determine if elevated liver enzyme activity was a reversible process following successful iodine-131 treatment.
Methods: Cases that presented for a single iodine-131 treatment were retrospectively reviewed. Short-term and long-term follow-up clinicopathologic data was then reviewed for the secondary objective.
Results: Two hundred seventeen hyperthyroid cats met the inclusion criteria for the primary objective. In total, 123/217 (56.7%) of the cats had at least one liver enzyme elevation on their chemistry panel, with alanine transaminase activity being the most common. All cats who were successfully treated with iodine-131 had liver enzyme activity within the reference range at short-term follow-up and long-term follow-up points.
Conclusion and relevance: Our study demonstrates that elevated liver values are common in cats presenting for iodine-131 treatment. Additionally, our study demonstrates that even when liver values are markedly elevated prior to treatment, the liver enzyme activity will return to normal after successful resolution of hyperthyroidism using iodine-131 treatment. Investigation into hepatobiliary disease and liver function tests for cats with a diagnosis of hyperthyroidism may be unnecessary as the liver values will likely return to normal with successful iodine-131 treatment.
Keywords: I-131 treatment; clinical pathology data; feline hyperthyroidism; liver enzyme elevations; thyroid nodular hyperplasia.
Copyright © 2022 Campbell, Chapman and Klag.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


References
-
- Graves TK. Feline hyperthyroidism. In: Ettinger SJ, Feldman EC, Cote E. editors. Textbook of Veterinary Internal Medicine. 8th ed. St. Louis, Missouri: Elsevier; (2017). p. 1747–57.
-
- Scott-Moncrieff JC. Feline hyperthyroidism. In: Feldman EC, Nelson RW, Reusch C, Scott-Moncrieff JC. editors. Canine and Feline Endocrinology. 4th ed. St. Louis, Missouri: Elsevier; (2015). p. 136–195. 10.1016/B978-1-4557-4456-5.00004-3 - DOI
-
- Trepanier LA. Web chapter 19: medical treatment of feline hyperthyroidism. In: Bonagura JD, Twedt DC. editors. Kirk's Current Veterinary Therapy XV. 1st ed. St. Louis, Missouri: Elsevier; (2013). p. e102–6.
-
- Meric SM, Rubin SI. Serum thyroxine concentrations following fixed-dose radioactive iodine treatment in hyperthyroid cats: 62 cases (1986–1989). J Am Vet Med Assoc. (1990) 197:621–3. - PubMed
-
- Peterson ME, Becker DV. Radioiodine treatment of 524 cats with hyperthyroidism. J Am Vet Med Assoc. (1995) 207:1422–8. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous